Men diagnosed with prostate cancer during 2020, the start of the pandemic, were more likely to have higher-stage and higher-grade disease compared with men diagnosed in 2018-2019, according to investigators.
As cumulative occupational exposure to benzene-toluene-zylene increases, so does the risk for bladder cancer, new data suggest.
A population-based study of Swedish adults found that ANCA-associated vasculitis is more prevalent among men than women.
Approximately 1 in 6 patients with ANCA-associated vasculitis found to have osteonecrosis of the femoral head.
A study examined 30,969 individuals aged 20 years or older who participated in the National Health and Nutrition Examination Survey from 2007 to 2018.
Among men with intermediate- and high-risk disease, Black men had significant 22% and 37% lower odds of receiving definitive treatment, respectively, compared with White men, a study found.
In the VHA system, use of doublet therapy increased to more than 50% of mHSPC cases since 2020.
New study corroborates findings from a prior study of men receiving care in the Veterans Health Administration system.
Investigators estimated prevalence based on the number of de novo and recurrent cases of metastatic prostate cancer.
The higher risk of hyponatremia among women vs men persisted regardless of diuretic type.
